Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a pair of phase 3 trials. The Protagonist Therapeutics-partnered IL-23 ...

When psoriasis develops on your feet, it can cause uncomfortable itching or soreness that makes tasks like walking difficult. Psoriasis, an autoimmune skin condition, usually causes scaly rashes ...

Some evidence suggests a higher risk of liver disease with psoriasis. Certain psoriasis treatments can cause liver toxicity, but the two conditions also share common risk factors, which may ...

Knowing the foods to avoid with psoriasis can be part of managing a disease known to flare up due to diet and nutrition. Certain foods, such as red meats or processed snacks, can promote inflammation ...

Psoriasis frequently appears on the arms, often on your elbow. Several types of psoriasis may affect your arms, but plaque psoriasis is the most common. The earliest sign may be a small bump, but the ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...